PRDX3 and Hepatic fibrosis: Indeed, Sun et al. (2022) revealed that peroxiredoxin 3 (PRDX3), whose translation was upregulated by m6A reader YTHDF3, operated as a suppressor of HSC activation and liver fibrosis through the (ROS)/TGF-β1/Smad2/3 pathway.